Ondas Just Unlocked Billion in DoD Deals After Mistral Merge
Ondas Holdings rides a Mistral merger to prime DoD contractor status, unlocking access to more than $1 billion in def...
Ways To Account For Unexpected Costs In Budget
Budget gaps from surprises can be closed with short contingency lines and proactive forecasting. Find quick fixes to keep your plan intact.
21,573 articles
This $19.8 Million Commvault Bet: Investor Insights
As Commvault shares dive, a fresh $19.8 million stake signals confidence from a hedge fund with a plan. Here's how to...
Rad Intel Bets on a Market Where Live Forever: Final Window
Rad Intel is sprinting toward a final fundraising window as it pitches an AI-powered platform designed to curb the ri...
Why a Fund Made Million MercadoLibre Bet Surprised Markets
A disciplined fund made million MercadoLibre bets after a 35% slide, betting on a resilient platform in LATAM. This d...
Billionaires Losing Faith? Institutional Investors Losing Nvidia Bet in Perspective
AAI disruption is reshaping markets, and Nvidia sits at the center. This piece breaks down how billionaires instituti...
Better After Chip Sell-Off: Nvidia or AMD Buyers Guide
When chip stocks swing, choosing the right side matters. This guide weighs Nvidia vs AMD after the sell-off, with num...
Massive News Stock Market: Practical Steps for Investors
Sudden headlines can move markets, but smart investors stay calm and plan. This guide breaks down how to interpret ma...
OpenAI Partners with McKinsey and Top Firms for Frontier AI
OpenAI expands its enterprise push by tying up with four global consultancies to accelerate Frontier AI adoption. The...
Best Industrial Stocks March: Top 3 Picks to Watch
March is a pivotal time for industrial stocks as infrastructure and defense themes collide with energy transition dem...
Palantir Technologies (PLTR) Stock Outlook 2026–2030
Palantir Technologies is at a crossroads as AI-driven data analytics demand tightens. This long-range look maps 2026-...
Why This Biotech Fund Increased Its Oruka Stake Amid a 500% Rally
A biotech fund just boosted its Oruka Therapeutics position after a blistering rally. Here’s what the move signals ab...
Prediction: This Will Palantir's Stock by End 2027
What could Palantir's stock do by the end of 2027? This article builds three forward-looking scenarios, weighs risks,...
Popular Topics
Fable
Smart Money Moves For Everyday Life
Investment Strategies In Energy Sector
Best Index Funds For Retirement
Investment Strategies
Untitled D6eff7ea
Crypto For Beginners
Best Dividend Etfs
Index
Innovative Skincare Clinical
Dutch Salary
Blue Owl
Budget
Ai Healthcare News
Penalty Vs No Penalty Depending On Lock Status